Financials
Value Q1, 25Q2, 25 TTM Selling/general/admin expenses 2.77 B2.91 B 11.16 B Research & development —— — Operating income 638.52 M769.16 M 2.44 B Non-Operating Income, Total —— — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses —— — Unusual income/expense —— — Pretax income 591.28 M726.28 M 2.23 B Equity in earnings —— — Taxes 147.15 M175.97 M 529.54 M Non-controlling/minority interest —— — After tax other income/expense -1.16 M-28.77 M -197.8 M Net income before discontinued operations 444.13 M550.32 M 1.7 B Discontinued operations —— — Net income 444.13 M550.32 M 1.7 B Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 444.13 M550.32 M 1.7 B Basic earnings per share (Basic EPS) 2.022.49 7.73 Diluted earnings per share (Diluted EPS) 22.48 7.69 Average basic shares outstanding 220.35 M220.61 M — Diluted shares outstanding 221.56 M221.5 M — EBITDA 909.35 M1.05 B 3.52 B EBIT 638.52 M769.16 M 2.44 B Cost of revenue 7.38 B7.61 B 30.04 B Other cost of goods sold —— — Depreciation & amortization (cash flow) 270.83 M277.5 M 1.09 B